Anti-Microbial Flooring and Surfaces


Cuprafloor ™ is an anti-bacterial floor coating designed and developed by Anti Bacterial Coatings and Guaranteed Asphalt Limited. With hospital floors, walls and surfaces in mind, we set out to find a solution to the problem of infections being spread due to the resilience of superbugs such as MRSA and C-Difficile lasting up to seven months on unprotected surfaces.


These organisms are the major cause of hospital infections and cost health authorities many billions of pounds in extra healthcare for the affected patients notwithstanding the pain and suffering and often death to those affected and untold distress for their families.

The global gold standard for the efficacy of such a coating is set by the American Environmental Protection Agency and over a series of trials and light microscopy procedures we have managed to achieve the kill-rates required by the EPA to successfully extinguish such superbug levels to zero well within the required time. Cuprafloor ™ passed these tests, and have shown to destroy the DNA of these superbugs, thereby preventing any regrowth by the organisms. A dry surface Cuprafloor ™ sample managed a kill rate of 99.9% death within 6 minutes, far exceeding  the EPA gold standard of two hours, with the wet surface test passing also well within this required time.The main ingredient of our product is copper, which has been shown to have unparalleled anti-microbial properties. The US defense department recently carried out a three year study using copper and copper-alloy accessories such as door handles and taps within a clinical environment and consistently showed a 60-75% drop in infectious presence using these simple accessories against stainless steel equivalent.


Dr. Bill Keevil, Head of The Environmental HealthCare Unit, The School of Biological Sciences at Southampton University, is the world’s leading researcher in pathogen survival and scientific advisor to the House of Commons Select Committee on Science and Technology, He personally carried out the tests on Cuprafloor in the UK and when asked about the efficacy of our product, He agreed that such a floor surface would undoubtedly further reduce the infectious presence shown in the US DoD’s trials, possibly even to zero.

This is because pathogens repeatedly become airborne from floor and other surfaces, as they are able to survive on the skin, clothes and feet of the people present within the hospital environment. Simply having anti-microbial touch surfaces, such as taps and door handles will not eradicate the bugs entirely. Once the floor, and other surfaces are protected, this will provide a much more solid defense against the superbugs. This will mean that hospitals are not reliant simply on a cleaning regime to eradicate these hidden killers.